Men Needed For Low Testosterone Trial
Posted on: Wednesday, 4 November 2009, 11:25 CST
Baylor College of Medicine has been selected as one of 12 sites nationwide to conduct a study to determine if elderly men with low testosterone will benefit from testosterone treatment.
"We are conducting this study because low testosterone levels can adversely affect the health of older men in several critical areas," said Dr. Glenn Cunningham, professor of medicine-endocrinology and principal investigator for the study at BCM. "If this treatment proves effective, we may be able to help older men with low testosterone levels remain healthy and independent longer than would have been possible otherwise."
To qualify for the study, male volunteers must:
* Be 65 years of age or older
* Have at least one of the following symptoms: trouble walking, less interest in sex or less energy
* Have low testosterone levels when measured by blood tests at the trial site
The National Institute on Aging is the primary source of support for this trial. Additional funding is being provided by the National Heart, Lung, and Blood Institute; the National Institute on Neurological Disorders and Stroke; the Eunice Kennedy Shriver National Institute of Child Health and Human Development and Solvay Pharmaceuticals, which is also supplying the study drug.
Volunteers will be compensated for their time and effort.
For more information about the study, call 713-798-8343 or e-mail ecordero@bcm.edu.
---
On the Net:
Related Articles
- National Institutes of Health Begins Study of CHF Solutions' Aquapheresis(TM) Therapy
- National Institute of Aging Funding to Study the Beneficial Effects of SIRT1 Activation on Diseases of Aging
- Skirball Hospice Awarded Accreditation From the National Institute of Jewish Hospice
- MedImmune and National Institutes of Health Begin Clinical Testing of a Live, Attenuated Intranasal Vaccine Against an H5N1 Avian Influenza Virus
- Cleveland Clinic Receives $13.5 Million Grant From the National Institutes of Health
- Journal of the American Medical Association/National Institutes of Health to Announce Dietary Findings of the Women's Health Initiative
- Acumen Pharmaceuticals Receives SBIR Award From National Institute on Aging
- National Institutes of Health Accept Clinical Study of Zestra (TM) for Women
- UK's National Institute for Health and Clinical Excellence Approves PVP Procedure at National Health Service Hospitals
- UK National Institute for Clinical Excellence Backs the Use of HIFU for the Treatment of Localized Prostate Cancer
 |
 |
User Comments (0)
RSS Feeds